Targeted use of prednisolone with the second IVIG dose for refractory Kawasaki disease.
Kimura M, Harazaki M, Fukuoka T, Asakura I, Sakai H, Kamimaki T, Ohkawara I, Akiyama N, Tsurui S, Iwashima S, Shimomura M, Morishita H, Meguro T, Seto S.
Kimura M, et al. Among authors: seto s.
Pediatr Int. 2017 Apr;59(4):397-403. doi: 10.1111/ped.13190. Epub 2016 Dec 19.
Pediatr Int. 2017.
PMID: 27743415
Clinical Trial.